Philip Rosenfeld
Philip Rosenfeld
Bascom Palmer Eye Institute
Потвърден имейл адрес: miami.edu
Заглавие
Позовавания
Позовавания
Година
Ranibizumab for neovascular age-related macular degeneration
PJ Rosenfeld, DM Brown, JS Heier, DS Boyer, PK Kaiser, CY Chung, ...
New England Journal of Medicine 355 (14), 1419-1431, 2006
60512006
Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for neovascular age-related macular degeneration
PJ Rosenfeld, AA Moshfeghi, CA Puliafito
Ophthalmic Surgery, Lasers and Imaging Retina 36 (4), 331-335, 2005
12452005
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration
AE Fung, GA Lalwani, PJ Rosenfeld, SR Dubovy, S Michels, WJ Feuer, ...
American journal of ophthalmology 143 (4), 566-583. e2, 2007
11392007
A cellular DNA-binding protein that activates eukaryotic transcription and DNA replication
KA Jones, JT Kadonaga, PJ Rosenfeld, TJ Kelly, R Tjian
Cell 48 (1), 79-89, 1987
11311987
Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label …
SD Schwartz, CD Regillo, BL Lam, D Eliott, PJ Rosenfeld, NZ Gregori, ...
The Lancet 385 (9967), 509-516, 2015
11212015
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study
GA Lalwani, PJ Rosenfeld, AE Fung, SR Dubovy, S Michels, W Feuer, ...
American journal of ophthalmology 148 (1), 43-58. e1, 2009
10402009
Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twelve-week results of an uncontrolled open-label clinical study
S Michels, PJ Rosenfeld, CA Puliafito, EN Marcus, AS Venkatraman
Ophthalmology 112 (6), 1035-1047. e9, 2005
8842005
The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide
AE Fung, PJ Rosenfeld, E Reichel
British Journal of Ophthalmology 90 (11), 1344-1349, 2006
7232006
Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin®) for macular edema from central retinal vein occlusion
PJ Rosenfeld, AE Fung, CA Puliafito
Ophthalmic Surgery, Lasers and Imaging Retina 36 (4), 336-339, 2005
6712005
Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration
RM Rich, PJ Rosenfeld, CA Puliafito, SR Dubovy, JL Davis, HW Flynn Jr, ...
Retina 26 (5), 495-511, 2006
6542006
Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study
JS Heier, AN Antoszyk, PR Pavan, SR Leff, PJ Rosenfeld, TA Ciulla, ...
Ophthalmology 113 (4), 633-642. e4, 2006
4882006
Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications
AH Kashani, CL Chen, JK Gahm, F Zheng, GM Richter, PJ Rosenfeld, ...
Progress in retinal and eye research 60, 66-100, 2017
4602017
A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa
PJ Rosenfeld, GS Cowley, TL McGee, MA Sandberg, EL Berson, TP Dryja
Nature genetics 1 (3), 209-213, 1992
4521992
Predicted biological activity of intravitreal VEGF Trap
MW Stewart, PJ Rosenfeld
British Journal of Ophthalmology 92 (5), 667-668, 2008
4312008
Ranibizumab: Phase III clinical trial results.
PJ Rosenfeld, RM Rich, GA Lalwani
Ophthalmology clinics of North America 19 (3), 361-372, 2006
4022006
Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy
RH Loo, IU Scott, HW Flynn Jr, JDM Gass, TG Murray, ML Lewis, ...
Retina 22 (1), 19-24, 2002
3882002
Purification of nuclear factor I by DNA recognition site affinity chromatography.
PJ Rosenfeld, TJ Kelly
Journal of Biological Chemistry 261 (3), 1398-1408, 1986
3771986
Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin-1-year results of a randomized clinical trial-VIP report no. 1
J Arnold, D Kilmartin, J Olson, S Neville, K Robinson, A Laird, ...
Ophthalmology 108 (ARTICLE), 841-852, 2001
3682001
Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
KJ Blinder, MS Blumenkranz, NM Bressler, SB Bressler, G Donato, ...
Ophthalmology 110 (4), 667-673, 2003
3642003
Novel method for analyzing snellen visual acuity measurements
NZ Gregori, W Feuer, PJ Rosenfeld
Retina 30 (7), 1046-1050, 2010
3422010
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20